The stem cell services market size has grown rapidly in recent years. It will grow from $17.27 billion in 2025 to $19.14 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to expansion of stem cell research activities, increasing use of cell-based assays in drug development, rising demand for long-term stem cell storage, growth of biopharmaceutical r&d pipelines, increasing regulatory standardization.
The stem cell services market size is expected to see rapid growth in the next few years. It will grow to $28.66 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing investments in personalized medicine services, rising demand for IPSC-based research solutions, expansion of regenerative medicine applications, growing outsourcing of stem cell services by pharma companies, increased adoption of digital laboratory platforms. Major trends in the forecast period include increasing adoption of advanced stem cell banking services, growing demand for customized stem cell processing, rising adoption of high-throughput cell screening services, increasing integration of data-driven cell analytics, enhanced focus on quality and regulatory compliance.
The growing demand for personalized therapies is expected to significantly drive the growth of the stem cell services market. Personalized therapies are medical treatments tailored to an individual’s genetic makeup, lifestyle, and specific disease characteristics, aiming to maximize effectiveness and minimize side effects by targeting each patient’s unique biological profile. The increase in demand for personalized therapies is fueled by advancements in genetic testing and molecular diagnostics, which allow treatments to be customized to an individual’s specific biological and genetic characteristics, improving outcomes and reducing adverse effects. Stem cell services support personalized therapies by providing patient-specific stem cells and customized regenerative solutions, enabling precise and targeted treatment strategies that align with each individual’s biological profile. For instance, in April 2024, the Personalized Medicine Coalition (PMC), a U.S.-based advocacy organization for personalized healthcare, reported that of the 50 new molecular entities (NMEs) approved by the U.S. FDA’s Center for Drug Evaluation and Research (CDER) in 2024, 18 (approximately 38%) were classified as personalized medicines. Therefore, the growing demand for personalized therapies is expected to drive the expansion of the stem cell services market.
Major companies in the stem cell services market are focusing on innovations such as single-use consumable systems to enhance process efficiency, minimize contamination risks, and streamline end-to-end cell therapy manufacturing. A single-use consumable system is a manufacturing approach in which equipment that comes into contact with biological materials is designed for one-time use, reducing contamination risk and improving production efficiency. For instance, in March 2025, Limula SA, a Switzerland-based life sciences tools company, launched LimONE, an integrated platform for end-to-end cell therapy manufacturing. This system automates and consolidates complex, fragmented processes into a single seamless workflow, reducing labor, equipment, and infrastructure requirements while ensuring process standardization, scalability, and faster production timelines for highly personalized cell therapies.
In December 2024, Novo Holdings A/S, a Denmark-based investment and holding company, acquired Catalent, Inc. for an undisclosed amount. Through this acquisition, Novo Holdings aims to strengthen its position in the biopharmaceutical sector by expanding strategic investments and collaborations, including leveraging Catalent’s advanced development and manufacturing capabilities to accelerate the delivery of innovative therapies. Catalent, Inc., is a U.S.-based life sciences company providing services for stem cell therapies and regenerative medicine.
Major companies operating in the stem cell services market are Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation, Lonza Group AG, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Miltenyi Biotec B.V. & Co. KG, AGC Biologics Inc., GenScript Biotech Corporation, Vericel Corporation, LifeCell International Private Limited, Cryo-Cell International Inc., Reelabs Private Limited, Medipost Co. Ltd., Celltex Therapeutics Corporation, Kangstem Biotech Co. Ltd., CellThera Ltd., Anterogen Co. Ltd., Healios K.K., Sanpower Group Co. Ltd., InoCells Co. Ltd.
North America was the largest region in the stem cell services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the stem cell services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the stem cell services market by raising costs of imported analytical instruments, cell culture reagents, cryogenic storage systems, and bioinformatics software platforms. Research institutes and pharmaceutical companies in North America and Europe are most affected due to dependence on imported high-end laboratory equipment, while Asia-Pacific experiences cost pressure on service scalability. These tariffs are increasing operational expenses and service pricing. At the same time, they are encouraging domestic production of laboratory consumables, regional service partnerships, and localized development of stem cell processing capabilities.
The stem cell services market research report is one of a series of new reports that provides stem cell services market statistics, including stem cell services industry global market size, regional shares, competitors with a stem cell services market share, detailed stem cell services market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell services industry. This stem cell services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Stem cell services encompass a variety of medical and scientific services focused on the collection, processing, preservation, and application of stem cells for therapeutic and research purposes. These services ensure the availability of high-quality stem cells for regenerative medicine, disease treatment, and scientific advancement.
The main components of stem cell services include customized services, stem cell differentiation, assay development, screening, and other types. Customized services provide tailored solutions to optimize stem cell handling, culture, differentiation, and analysis to meet specific research or therapeutic requirements. The types of stem cells covered include embryonic stem cells, adult stem cells, and induced pluripotent stem cells (iPSCs). Therapy types include autologous and allogeneic stem cell therapies. Applications span regenerative medicine, stem cell banking, cell-based assays, and drug discovery and development. End users include hospitals, research institutes, pharmaceutical companies, and biotechnology firms.
The stem cell services market includes revenues earned by entities by providing services such as stem cell line development services, clinical trial support services, training and educational services, stem cell therapy development services, and bioinformatics and data analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The stem cell services market size is expected to see rapid growth in the next few years. It will grow to $28.66 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing investments in personalized medicine services, rising demand for IPSC-based research solutions, expansion of regenerative medicine applications, growing outsourcing of stem cell services by pharma companies, increased adoption of digital laboratory platforms. Major trends in the forecast period include increasing adoption of advanced stem cell banking services, growing demand for customized stem cell processing, rising adoption of high-throughput cell screening services, increasing integration of data-driven cell analytics, enhanced focus on quality and regulatory compliance.
The growing demand for personalized therapies is expected to significantly drive the growth of the stem cell services market. Personalized therapies are medical treatments tailored to an individual’s genetic makeup, lifestyle, and specific disease characteristics, aiming to maximize effectiveness and minimize side effects by targeting each patient’s unique biological profile. The increase in demand for personalized therapies is fueled by advancements in genetic testing and molecular diagnostics, which allow treatments to be customized to an individual’s specific biological and genetic characteristics, improving outcomes and reducing adverse effects. Stem cell services support personalized therapies by providing patient-specific stem cells and customized regenerative solutions, enabling precise and targeted treatment strategies that align with each individual’s biological profile. For instance, in April 2024, the Personalized Medicine Coalition (PMC), a U.S.-based advocacy organization for personalized healthcare, reported that of the 50 new molecular entities (NMEs) approved by the U.S. FDA’s Center for Drug Evaluation and Research (CDER) in 2024, 18 (approximately 38%) were classified as personalized medicines. Therefore, the growing demand for personalized therapies is expected to drive the expansion of the stem cell services market.
Major companies in the stem cell services market are focusing on innovations such as single-use consumable systems to enhance process efficiency, minimize contamination risks, and streamline end-to-end cell therapy manufacturing. A single-use consumable system is a manufacturing approach in which equipment that comes into contact with biological materials is designed for one-time use, reducing contamination risk and improving production efficiency. For instance, in March 2025, Limula SA, a Switzerland-based life sciences tools company, launched LimONE, an integrated platform for end-to-end cell therapy manufacturing. This system automates and consolidates complex, fragmented processes into a single seamless workflow, reducing labor, equipment, and infrastructure requirements while ensuring process standardization, scalability, and faster production timelines for highly personalized cell therapies.
In December 2024, Novo Holdings A/S, a Denmark-based investment and holding company, acquired Catalent, Inc. for an undisclosed amount. Through this acquisition, Novo Holdings aims to strengthen its position in the biopharmaceutical sector by expanding strategic investments and collaborations, including leveraging Catalent’s advanced development and manufacturing capabilities to accelerate the delivery of innovative therapies. Catalent, Inc., is a U.S.-based life sciences company providing services for stem cell therapies and regenerative medicine.
Major companies operating in the stem cell services market are Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation, Lonza Group AG, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Miltenyi Biotec B.V. & Co. KG, AGC Biologics Inc., GenScript Biotech Corporation, Vericel Corporation, LifeCell International Private Limited, Cryo-Cell International Inc., Reelabs Private Limited, Medipost Co. Ltd., Celltex Therapeutics Corporation, Kangstem Biotech Co. Ltd., CellThera Ltd., Anterogen Co. Ltd., Healios K.K., Sanpower Group Co. Ltd., InoCells Co. Ltd.
North America was the largest region in the stem cell services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the stem cell services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the stem cell services market by raising costs of imported analytical instruments, cell culture reagents, cryogenic storage systems, and bioinformatics software platforms. Research institutes and pharmaceutical companies in North America and Europe are most affected due to dependence on imported high-end laboratory equipment, while Asia-Pacific experiences cost pressure on service scalability. These tariffs are increasing operational expenses and service pricing. At the same time, they are encouraging domestic production of laboratory consumables, regional service partnerships, and localized development of stem cell processing capabilities.
The stem cell services market research report is one of a series of new reports that provides stem cell services market statistics, including stem cell services industry global market size, regional shares, competitors with a stem cell services market share, detailed stem cell services market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell services industry. This stem cell services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Stem cell services encompass a variety of medical and scientific services focused on the collection, processing, preservation, and application of stem cells for therapeutic and research purposes. These services ensure the availability of high-quality stem cells for regenerative medicine, disease treatment, and scientific advancement.
The main components of stem cell services include customized services, stem cell differentiation, assay development, screening, and other types. Customized services provide tailored solutions to optimize stem cell handling, culture, differentiation, and analysis to meet specific research or therapeutic requirements. The types of stem cells covered include embryonic stem cells, adult stem cells, and induced pluripotent stem cells (iPSCs). Therapy types include autologous and allogeneic stem cell therapies. Applications span regenerative medicine, stem cell banking, cell-based assays, and drug discovery and development. End users include hospitals, research institutes, pharmaceutical companies, and biotechnology firms.
The stem cell services market includes revenues earned by entities by providing services such as stem cell line development services, clinical trial support services, training and educational services, stem cell therapy development services, and bioinformatics and data analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Stem Cell Services Market Characteristics
3. Stem Cell Services Market Supply Chain Analysis
4. Global Stem Cell Services Market Trends and Strategies
5. Stem Cell Services Market Analysis of End Use Industries
7. Global Stem Cell Services Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Stem Cell Services Total Addressable Market (TAM) Analysis for the Market
9. Stem Cell Services Market Segmentation
10. Stem Cell Services Market Regional and Country Analysis
11. Asia-Pacific Stem Cell Services Market
12. China Stem Cell Services Market
13. India Stem Cell Services Market
14. Japan Stem Cell Services Market
15. Australia Stem Cell Services Market
16. Indonesia Stem Cell Services Market
17. South Korea Stem Cell Services Market
18. Taiwan Stem Cell Services Market
19. South East Asia Stem Cell Services Market
20. Western Europe Stem Cell Services Market
21. UK Stem Cell Services Market
22. Germany Stem Cell Services Market
23. France Stem Cell Services Market
24. Italy Stem Cell Services Market
25. Spain Stem Cell Services Market
26. Eastern Europe Stem Cell Services Market
27. Russia Stem Cell Services Market
28. North America Stem Cell Services Market
29. USA Stem Cell Services Market
30. Canada Stem Cell Services Market
31. South America Stem Cell Services Market
32. Brazil Stem Cell Services Market
33. Middle East Stem Cell Services Market
34. Africa Stem Cell Services Market
36. Stem Cell Services Market Competitive Landscape and Company Profiles
37. Stem Cell Services Market Other Major and Innovative Companies
40. Stem Cell Services Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Stem Cell Services Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses stem cell services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for stem cell services? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stem cell services market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Customize Service; Stem Cell Differentiation; Assay Development; Screening; Other Types2) By Type Of Stem Cells: Embryonic Stem Cells; Adult Stem Cells; Induced Pluripotent Stem Cells (iPSCs)
3) By Therapy Type: Autologous Stem Cell Therapy; Allogenic Stem Cell Therapy
4) By Application: Regenerative Medicine; Stem Cell Banking; Cell-Based Assays; Drug Discovery And Development
5) By End User: Hospitals; Research Institutes; Pharmaceutical Companies; Biotechnology Companies
Subsegments:
1) By Customize Service: Personalized Protocol Design; Tailored Culture Conditions; Patient Specific Cell Processing; Custom Analytical Reporting2) By Stem Cell Differentiation: Mesenchymal Lineage Differentiation; Neural Lineage Differentiation; Hematopoietic Lineage Differentiation; Cardiac Lineage Differentiation
3) By Assay Development: Functional Assay Design; Cellular Assay Optimization; Biomarker Assay Development; High Throughput Assay Design
4) By Screening: Small Molecule Screening; Drug Candidate Screening; Gene Editing Screening; Toxicity Screening
5) By Other Types: Cell Banking Services; Quality Control Testing; Process Development Support; Bioinformatics Analysis
Companies Mentioned: Thermo Fisher Scientific Inc.; FUJIFILM Holdings Corporation; Lonza Group AG; WuXi AppTec Co. Ltd.; Charles River Laboratories International Inc.; Miltenyi Biotec B.V. & Co. KG; AGC Biologics Inc.; GenScript Biotech Corporation; Vericel Corporation; LifeCell International Private Limited; Cryo-Cell International Inc.; Reelabs Private Limited; Medipost Co. Ltd.; Celltex Therapeutics Corporation; Kangstem Biotech Co. Ltd.; CellThera Ltd.; Anterogen Co. Ltd.; Healios K.K.; Sanpower Group Co. Ltd.; InoCells Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Stem Cell Services market report include:- Thermo Fisher Scientific Inc.
- FUJIFILM Holdings Corporation
- Lonza Group AG
- WuXi AppTec Co. Ltd.
- Charles River Laboratories International Inc.
- Miltenyi Biotec B.V. & Co. KG
- AGC Biologics Inc.
- GenScript Biotech Corporation
- Vericel Corporation
- LifeCell International Private Limited
- Cryo-Cell International Inc.
- Reelabs Private Limited
- Medipost Co. Ltd.
- Celltex Therapeutics Corporation
- Kangstem Biotech Co. Ltd.
- CellThera Ltd.
- Anterogen Co. Ltd.
- Healios K.K.
- Sanpower Group Co. Ltd.
- InoCells Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 19.14 Billion |
| Forecasted Market Value ( USD | $ 28.66 Billion |
| Compound Annual Growth Rate | 10.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
